News Author: Neil Osterweil Publish date: June 12, 2016
The experimental antibody-drug conjugate inotuzumab ozogamicin was associated with a nearly threefold higher complete remission rate than standard int...
News Author: Neil Osterweil Publish date: June 11, 2016
A real-life comparison of major bleeding risk with anticoagulants showed that in-hospital mortality was lower with novel oral agents than with vitamin...
News Author: Neil Osterweil Publish date: June 11, 2016
ETV6-related thrombocytopenia (EV6-RT) appears to predispose carriers to acute lymphoblastic leukemia and other hematologic cancers.
News Author: Neil Osterweil Publish date: June 11, 2016
The higher risk of acute myeloid leukemia relapse among older patients may be due to persistent pre-leukemic mutations.
News Author: Neil Osterweil Publish date: May 23, 2016
Key clinical point: Early cessation of aromatase inhibitor therapy is associated with reduced disease-free survival in postmenopausal women with e...
News Author: Neil Osterweil Publish date: May 23, 2016
Key clinical point: The experimental agent enzastaurin was no better than placebo as maintenance therapy in patients who had achieved a complete re...
News Author: Neil Osterweil Publish date: May 23, 2016
Key clinical point: The combination of a vascular disrupter and antiangiogenic agent improved progression-free survival in epithelial cancers of t...
News Author: Neil Osterweil Publish date: May 23, 2016
Key clinical point: A 21-gene recurrence score is strongly prognostic for late distant recurrence of breast cancer in patients with higher quantit...
News Author: Neil Osterweil Publish date: May 23, 2016
Key clinical point: Hormonal therapy should be offered to patients whose tumors express any level of estrogen and/or progesterone receptors, accor...
News Author: Neil Osterweil Publish date: May 9, 2016
Key clinical point: This study demonstrates an association between smoking, DNA methylation, and potentially pathogenic genetic changes.
Major fin...
News Author: Neil Osterweil Publish date: May 3, 2016
Regular aspirin use is associated with an approximately threefold reduction in risk for the three major subtypes of cholangiocarcinoma, results of a c...
News Author: Neil Osterweil Publish date: May 2, 2016
Key clinical point: The immune checkpoint inhibitor pembrolizumab may be effective against metastatic triple-negative breast cancer.
Major finding...
News Author: Neil Osterweil Publish date: April 14, 2016
Key clinical point: Clinicians should understand patients’ coping styles and personalities before making recommendations about comparable tr...
News Author: Neil Osterweil Publish date: April 13, 2016
News Author: Neil Osterweil Publish date: April 13, 2016
